A Pune-based IT professional has filed an FIR alleging an extortion campaign that resulted in a loss of ₹21 lakh, which was triggered after a society-level dispute involving stray dogs and a caste ...

Pawar reached the site around 6.30 am, accompanied by senior officials from PMRDA, MIDC, PCMC, PMC, the police department ...

A major power outage caused by a fault in underground high-tension cables has disrupted electricity supply to over 52,000 consumers, including 70 to 90 IT and ITES firms, in Hinjewadi, Pune, for the ...

The Hinjewadi IT Park area in Pune has witnessed major power outages since Sunday afternoon. The widespread power outage affected more than 52,000 electricity users across the Ganeshkhind and Pune ...

Pune: After a gruelling four-day power outage, electricity supply to all commercial and residential units in Hinjewadi was restored by 12.30pm on Wedn.

A major power outage, triggered by a fault in underground high-tension cables, has left over 52,000 consumers in Hinjewadi, Pune, without electricity for two days, impacting 70 to 90 IT firms. While ...

Shapoorji Pallonji Real Estate's premium housing project is part of a 1,000-acre integrated township near Bavdhan, Pune, the ...

The new Bavdhan, Pune project by Shapoorji Pallonji spans five acres and is expected to generate ₹800 crores in revenue..

The project will offer ~10 lakhs square feet of development with an estimated revenue potential of ~ INR 800 crore~  New Delhi: Shapoorji Pallonji Real Estate (SPRE), one of India’s most trusted ...

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 metabolic dysfunction-associated steatohepatitis (MASH) study, while still ...

Patients with obesity, with or without diabetes, lose up to 20% body weight and show A1c reductions with the novel agent maridebart cafraglutide, though nearly all experience GI side effects.

LAS VEGAS — In this video, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses his presentation at Clinical Trials at the Summit on the use of EyePoint’s Duravyu in ...